Changes in invasive pneumococcal disease caused by streptococcus pneumoniae serotype 1 following introduction of PCV10 and PCV13 : Findings from the PSERENADE project
PSERENADE Team; Bennett, Julia C.; Hetrich, Marissa K.; Quesada, Maria Garcia; Sinkevitch, Jenna N.; Knoll, Maria Deloria; Feikin, Daniel R.; Zeger, Scott L.; Kagucia, Eunice W.; Cohen, Adam L.; Ampofo, Krow; Brandileone, Maria Cristina C.; Bruden, Dana; Camilli, Romina; Castilla, Jesús; Chan, Guanhao; Cook, Heather; Cornick, Jennifer E.; Dagan, Ron; Dalby, Tine; Danis, Kostas; de Miguel, Sara; De Wals, Philippe; Desmet, Stefanie; Georgakopoulou, Theano; Gilkison, Charlotte; Grgic‐vitek, Marta; Hammitt, Laura L.; Hilty, Markus; Ho, Pak Leung; Jayasinghe, Sanjay; Kellner, James D.; Kleynhans, Jackie; Knol, Mirjam J.; Kozakova, Jana; Kristinsson, Karl G.; Ladhani, Shamez N.; Macdonald, Laura; Mackenzie, Grant A.; Mad’arová, Lucia; McGeer, Allison; Mereckiene, Jolita; Morfeldt, Eva; Mungun, Tuya; Muñoz‐almagro, Carmen; Nuorti, J Pekka; Paragi, Metka; Pilishvili, Tamara; Puentes, Rodrigo; Saha, Samir K.; Khan, Aalisha Sahu (2021)
PSERENADE Team
Bennett, Julia C.
Hetrich, Marissa K.
Quesada, Maria Garcia
Sinkevitch, Jenna N.
Knoll, Maria Deloria
Feikin, Daniel R.
Zeger, Scott L.
Kagucia, Eunice W.
Cohen, Adam L.
Ampofo, Krow
Brandileone, Maria Cristina C.
Bruden, Dana
Camilli, Romina
Castilla, Jesús
Chan, Guanhao
Cook, Heather
Cornick, Jennifer E.
Dagan, Ron
Dalby, Tine
Danis, Kostas
de Miguel, Sara
De Wals, Philippe
Desmet, Stefanie
Georgakopoulou, Theano
Gilkison, Charlotte
Grgic‐vitek, Marta
Hammitt, Laura L.
Hilty, Markus
Ho, Pak Leung
Jayasinghe, Sanjay
Kellner, James D.
Kleynhans, Jackie
Knol, Mirjam J.
Kozakova, Jana
Kristinsson, Karl G.
Ladhani, Shamez N.
Macdonald, Laura
Mackenzie, Grant A.
Mad’arová, Lucia
McGeer, Allison
Mereckiene, Jolita
Morfeldt, Eva
Mungun, Tuya
Muñoz‐almagro, Carmen
Nuorti, J Pekka
Paragi, Metka
Pilishvili, Tamara
Puentes, Rodrigo
Saha, Samir K.
Khan, Aalisha Sahu
2021
696
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202107046184
https://urn.fi/URN:NBN:fi:tuni-202107046184
Kuvaus
Peer reviewed
Tiivistelmä
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) con-taining ST1 antigen. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERE‐ NADE) project gathered ST1 IPD surveillance data from sites globally and aimed to estimate PCV10/13 impact on ST1 IPD incidence. We estimated ST1 IPD incidence rate ratios (IRRs) compar-ing the pre‐PCV10/13 period to each post‐PCV10/13 year by site using a Bayesian multi‐level, mixed-effects Poisson regression and all‐site IRRs using a linear mixed‐effects regression (N = 45 sites). Following PCV10/13 introduction, the incidence rate (IR) of ST1 IPD declined among all ages. After six years of PCV10/13 use, the all‐site IRR was 0.05 (95% credibility interval 0.04–0.06) for all ages, 0.05 (0.04–0.05) for <5 years of age, 0.08 (0.06–0.09) for 5–17 years, 0.06 (0.05–0.08) for 18–49 years, 0.06 (0.05–0.07) for 50–64 years, and 0.05 (0.04–0.06) for ≥65 years. PCV10/13 use in infant immunization programs was followed by a 95% reduction in ST1 IPD in all ages after approximately 6 years. Limited data availability from the highest ST1 disease burden countries using a 3+0 schedule constrains generalizability and data from these settings are needed.
Kokoelmat
- TUNICRIS-julkaisut [17001]